Invesco Pharmaceuticals ETF
PJP
94 hedge funds and large institutions have $74.5M invested in Invesco Pharmaceuticals ETF in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 5 closing their positions.
120% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 5
27% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 22
11% more capital invested
Capital invested by funds: $66.9M → $74.5M (+$7.56M)
4% more funds holding
Funds holding: 90 → 94 (+4)
1.32% less ownership
Funds ownership: 18.19% → 16.87% (-1.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$7.72M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.88M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.03M |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$906K |
| 5 |
Morgan Stanley
New York
|
+$853K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$1.53M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$1.39M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$696K |
| 4 |
Citigroup
New York
|
-$534K |
| 5 |
Chevy Chase Trust
Bethesda,
Maryland
|
-$400K |
PJP Hedge Fund Activity: Q3 2021 in Review
94 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q3 2021, worth a combined $74.5M — up 11% from $66.9M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new PJP positions and 5 closed out — a net gain of 6 holders — while 28 added to existing stakes and 22 trimmed.
The largest buyer was Wellington Management Group, opening a new position worth an estimated $7.72M. The largest seller was Bank of America, cutting an estimated $1.53M.
- 94 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q3 2021, up from 90 in Q2 2021.
- Funds reported $74.5M of Invesco Pharmaceuticals ETF stock for Q3 2021, up 11% quarter-over-quarter.
- 11 funds opened new Invesco Pharmaceuticals ETF positions in Q3 2021 and 5 closed out, a net change of +6 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q3 2021 was Wellington Management Group, an estimated $7.72M added.
- The largest Invesco Pharmaceuticals ETF seller in Q3 2021 was Bank of America, an estimated $1.53M sold.
Based on aggregated 13F filings for Q3 2021.